tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Sunshine Biopharma’s Nora Pharma launches NIOPEG

Sunshine Biopharma (SBFM) announced that its wholly owned Canadian subsidiary, Nora Pharma, has launched NIOPEG, the company’s first Biosimilar drug on the market. NIOPEG is a Biosimilar comparable to the reference biologic drug NEULASTA. Like NEULASTA, NIOPEG is a long-acting, pegylated form of recombinant human granulocyte colony-stimulating factor. It is indicated to decrease the incidence of infection in patients with non-myeloid malignancies receiving chemotherapy. NIOPEG is available in a prefilled syringe of 6mg/0.6mL.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1